This cutoff value was higher than the result of 1465 pg/mL of GDF15 threshold associated with recurrence reported in a previous study focused on patients with early NSCLC (stage I–II) and supports the association of GDF15 with advanced disease (Liu et al. 2016). Here, GDF15 is linked to non-small cell lung carcinoma.